NCT04737278View on ClinicalTrials.gov

Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

May 28, 2014

Study Completion Date

September 29, 2014

Conditions

NeuralgiaMyalgia

Interventions

DRUG

Cunermuspir

"Copper Niacin Chelate, 6.06 mg per capsule Non-medicinal ingredients:~Organic evaporated cane juice powder, hypromellose, titanium dioxide"

OTHER

Placebo

same non-medical ingredients and encapsulation as Intervention 1

Trial Locations (1)

N6A 5R8

KGK Synergize now KGK Science, London

All Listed Sponsors

lead

Mitosynergy LLC

INDUSTRY

NCT04737278 - Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain | Biotech Hunter | Biotech Hunter